Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.
Amifostine shows a good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep an upward tendency.
The prevalence of target diseases, the increasing demand for early detection of incurable diseases and the emergence of innovative applications, the market of amifostine is rapidly developing, people's preference for instant testing and personalized drugs is growing, and cost-effective laboratory testing And the emergence of integrated analysis systems is expected to bring new opportunities to businessmen in this market.
This report elaborates on the current development of the Amifostine industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Luye Pharma
Taj Pharmaceuticals
Sun Pharmaceutical
Merro Pharmaceutical
Mingren Pharma
By Type:
400mg/Dose
500mg/Dose
By Application:
Ovarian Cancer Adjuvant Therapy
Others
Head and Neck Cancer Adjuvant Therapy
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Amifostine Market Overview 2018-2029
-
1.1 China Amifostine Industry Development Overview
-
1.2 China Amifostine Industry Development History
-
1.3 China Amifostine Industry Market Size (2018-2029)
-
1.4 China Amifostine Market Analysis by Type from Production Side
-
1.4.1 China Amifostine Production Volume, Production Value and Growth Rate of 400mg/Dose (2018-2029)
-
1.4.2 China Amifostine Production Volume, Production Value and Growth Rate of 500mg/Dose (2018-2029)
-
1.5 China Amifostine Market Analysis by Application from Consumption End
-
1.5.1 China Amifostine Sales Volume, Sales Value and Growth Rate of Ovarian Cancer Adjuvant Therapy (2018-2029)
-
1.5.2 China Amifostine Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Amifostine Sales Volume, Sales Value and Growth Rate of Head and Neck Cancer Adjuvant Therapy (2018-2029)
-
1.6 China Amifostine Market Analysis by Region
-
1.6.1 North China Amifostine Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Amifostine Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Amifostine Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Amifostine Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Amifostine Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Amifostine Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Amifostine Market Size and Growth Rate from 2018-2029
Chapter 2 China Amifostine Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Amifostine Market Status and Competition at home and abroad in 2023
-
2.2.2 China Amifostine Market Status and Competition Analysis in 2023
-
2.2.3 China Amifostine Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Amifostine Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Amifostine Industry Development
Chapter 3 AmifostineIndustry Chain Analysis
-
3.1 Amifostine Industry Chain
-
3.2 Amifostine Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Amifostine Market
-
3.3 Amifostine Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Amifostine Market
Chapter 4 China Amifostine Market, by Type
-
4.1 China Amifostine Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Amifostine Total Production Volume and Growth Rate from Production Side
-
4.5 China Amifostine Production Volume and Growth Rate, by Type
-
4.5.1 China Amifostine Production Volume and Growth Rate of 400mg/Dose
-
4.5.2 China Amifostine Production Volume and Growth Rate of 500mg/Dose
Chapter 5 China Amifostine Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Amifostine Total Market Size and Growth Rate from Consumption End
-
5.5 China Amifostine Market Size and Growth Rate, by Application
-
5.5.1 China Amifostine Market Size and Growth Rate of Ovarian Cancer Adjuvant Therapy
-
5.5.2 China Amifostine Market Size and Growth Rate of Others
-
5.5.3 China Amifostine Market Size and Growth Rate of Head and Neck Cancer Adjuvant Therapy
Chapter 6 China Amifostine Market, by Region
-
6.1 China Amifostine Production Volume and Production Value, by Region
-
6.2 China Amifostine Sales Volume and Sales Value, by Region
Chapter 7 North China Amifostine Market Analysis
-
7.1 North China Amifostine Market, by Type
-
7.2 North China Amifostine Market, by Application
Chapter 8 Central China Amifostine Market Analysis
-
8.1 Central China Amifostine Market, by Type
-
8.2 Central China Amifostine Market, by Application
Chapter 9 South China Amifostine Market Analysis
-
9.1 South China Amifostine Market, by Type
-
9.2 South China Amifostine Market, by Application
Chapter 10 East China Amifostine Market Analysis
-
10.1 East China Amifostine Market, by Type
-
10.2 East China Amifostine Market, by Application
Chapter 11 Northeast China Amifostine Market Analysis
-
11.1 Northeast China Amifostine Market, by Type
-
11.2 Northeast China Amifostine Market, by Application
Chapter 12 Southwest China Amifostine Market Analysis
-
12.1 Southwest China Amifostine Market, by Type
-
12.2 Southwest China Amifostine Market, by Application
Chapter 13 Northwest China Amifostine Market Analysis
-
13.1 Northwest China Amifostine Market, by Type
-
13.2 Northwest China Amifostine Market, by Application
Chapter 14 Company Profiles
-
14.1 Luye Pharma
-
14.1.1 Luye Pharma Company Profile
-
14.1.2 Luye Pharma Amifostine Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Taj Pharmaceuticals
-
14.2.1 Taj Pharmaceuticals Company Profile
-
14.2.2 Taj Pharmaceuticals Amifostine Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Sun Pharmaceutical
-
14.3.1 Sun Pharmaceutical Company Profile
-
14.3.2 Sun Pharmaceutical Amifostine Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Merro Pharmaceutical
-
14.4.1 Merro Pharmaceutical Company Profile
-
14.4.2 Merro Pharmaceutical Amifostine Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Mingren Pharma
-
14.5.1 Mingren Pharma Company Profile
-
14.5.2 Mingren Pharma Amifostine Market Performance
-
14.5.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Amifostine Industry Research Conclusions
-
15.2 Amifostine Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Amifostine Industry Market Size (2018-2029)
-
Figure China Amifostine Production Volume, Production Value and Growth Rate of 400mg/Dose (2018-2029)
-
Figure China Amifostine Production Volume, Production Value and Growth Rate of 500mg/Dose (2018-2029)
-
Figure China Amifostine Sales Volume, Sales Value and Growth Rate of Ovarian Cancer Adjuvant Therapy (2018-2029)
-
Figure China Amifostine Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Amifostine Sales Volume, Sales Value and Growth Rate of Head and Neck Cancer Adjuvant Therapy (2018-2029)
-
Figure North China Amifostine Market Size and Growth Rate from 2018-2029
-
Figure Central China Amifostine Market Size and Growth Rate from 2018-2029
-
Figure South China Amifostine Market Size and Growth Rate from 2018-2029
-
Figure East China Amifostine Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Amifostine Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Amifostine Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Amifostine Market Size and Growth Rate from 2018-2029
-
Figure Amifostine Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Amifostine Market Share by Type in 2018
-
Figure China Amifostine Market Share by Type in 2023
-
Figure China Amifostine Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Amifostine Production Volume and Growth Rate of 400mg/Dose (2018-2023)
-
Figure China Amifostine Production Volume and Growth Rate of 500mg/Dose (2018-2023)
-
Figure China Amifostine Market Share by Application in 2018
-
Figure China Amifostine Market Share by Application in 2023
-
Figure China Amifostine Total Market Size and Growth Rate from Consumption End
-
Figure China Amifostine Market Size and Growth Rate of Ovarian Cancer Adjuvant Therapy (2018-2023)
-
Figure China Amifostine Market Size and Growth Rate of Others (2018-2023)
-
Figure China Amifostine Market Size and Growth Rate of Head and Neck Cancer Adjuvant Therapy (2018-2023)
-
Table China Amifostine Production Volume by Region (2018-2023)
-
Table China Amifostine Production Volume Share by Region (2018-2023)
-
Figure China Amifostine Production Volume Share by Region (2018-2023)
-
Table China Amifostine Production Value by Region (2018-2023)
-
Table China Amifostine Production Value Share by Region (2018-2023)
-
Figure China Amifostine Production Value Share by Region (2018-2023)
-
Table China Amifostine Sales Volume by Region (2018-2023)
-
Table China Amifostine Sales Volume Share by Region (2018-2023)
-
Figure China Amifostine Sales Volume Share by Region (2018-2023)
-
Table China Amifostine Sales Value by Region (2018-2023)
-
Table China Amifostine Sales Value Share by Region (2018-2023)
-
Figure China Amifostine Sales Value Share by Region (2018-2023)
-
Table North China Amifostine Production Volume by Type (2018-2023)
-
Table North China Amifostine Production Volume Share by Type (2018-2023)
-
Figure North China Amifostine Production Volume Share by Type (2018-2023)
-
Table North China Amifostine Sales Volume by Application (2018-2023)
-
Table North China Amifostine Sales Volume Share by Application (2018-2023)
-
Figure North China Amifostine Sales Volume Share by Application (2018-2023)
-
Table Central China Amifostine Production Volume by Type (2018-2023)
-
Table Central China Amifostine Production Volume Share by Type (2018-2023)
-
Figure Central China Amifostine Production Volume Share by Type (2018-2023)
-
Table Central China Amifostine Sales Volume by Application (2018-2023)
-
Table Central China Amifostine Sales Volume Share by Application (2018-2023)
-
Figure Central China Amifostine Sales Volume Share by Application (2018-2023)
-
Table South China Amifostine Production Volume by Type (2018-2023)
-
Table South China Amifostine Production Volume Share by Type (2018-2023)
-
Figure South China Amifostine Production Volume Share by Type (2018-2023)
-
Table South China Amifostine Sales Volume by Application (2018-2023)
-
Table South China Amifostine Sales Volume Share by Application (2018-2023)
-
Figure South China Amifostine Sales Volume Share by Application (2018-2023)
-
Table East China Amifostine Production Volume by Type (2018-2023)
-
Table East China Amifostine Production Volume Share by Type (2018-2023)
-
Figure East China Amifostine Production Volume Share by Type (2018-2023)
-
Table East China Amifostine Sales Volume by Application (2018-2023)
-
Table East China Amifostine Sales Volume Share by Application (2018-2023)
-
Figure East China Amifostine Sales Volume Share by Application (2018-2023)
-
Table Northeast China Amifostine Production Volume by Type (2018-2023)
-
Table Northeast China Amifostine Production Volume Share by Type (2018-2023)
-
Figure Northeast China Amifostine Production Volume Share by Type (2018-2023)
-
Table Northeast China Amifostine Sales Volume by Application (2018-2023)
-
Table Northeast China Amifostine Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Amifostine Sales Volume Share by Application (2018-2023)
-
Table Southwest China Amifostine Production Volume by Type (2018-2023)
-
Table Southwest China Amifostine Production Volume Share by Type (2018-2023)
-
Figure Southwest China Amifostine Production Volume Share by Type (2018-2023)
-
Table Southwest China Amifostine Sales Volume by Application (2018-2023)
-
Table Southwest China Amifostine Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Amifostine Sales Volume Share by Application (2018-2023)
-
Table Northwest China Amifostine Production Volume by Type (2018-2023)
-
Table Northwest China Amifostine Production Volume Share by Type (2018-2023)
-
Figure Northwest China Amifostine Production Volume Share by Type (2018-2023)
-
Table Northwest China Amifostine Sales Volume by Application (2018-2023)
-
Table Northwest China Amifostine Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Amifostine Sales Volume Share by Application (2018-2023)
-
Table Luye Pharma Company Profile
-
Table Luye Pharma Amifostine Revenue, Price and Gross (2018-2023)
-
Table Taj Pharmaceuticals Company Profile
-
Table Taj Pharmaceuticals Amifostine Revenue, Price and Gross (2018-2023)
-
Table Sun Pharmaceutical Company Profile
-
Table Sun Pharmaceutical Amifostine Revenue, Price and Gross (2018-2023)
-
Table Merro Pharmaceutical Company Profile
-
Table Merro Pharmaceutical Amifostine Revenue, Price and Gross (2018-2023)
-
Table Mingren Pharma Company Profile
-
Table Mingren Pharma Amifostine Revenue, Price and Gross (2018-2023)
-
